Icrx Life Sciences Private Limited
About Icrx Life Sciences Private Limited
Data last updated:
Icrx Life Sciences Private Limited is a private limited company based in Anand, Gujarat, India, a subsidiary of Enhanced Compliance Inc.. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 25 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2019PTC106264.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Hoyt Randall Smith and Brijesh Magan Bhai Patel.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H/No.5180 Minal Tubewell Office Complex Samarkha Road Village: Samarkha, Anand, Gujarat, India – 388360.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.11 Lakh. For the same year it recorded a net profit of ₹15,941 (net margin 14.3%) and EBITDA of ₹15,941 (EBITDA margin 14.3%). Revenue has grown at a compounded annual rate (CAGR) of 62% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Icrx Life Sciences Private Limited's registered office is in Anand, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH/No.5180 Minal Tubewell Office Complex Samarkha Road Village: Samarkha, Anand, Gujarat, India – 388360
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Icrx Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Icrx Life Sciences Private Limited
FY 2025 filings availableIcrx Life Sciences Private Limited reported revenue of ₹1.11 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 62% over three years. EBITDA rose 179% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15,941 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15,941 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.3% | ||||
| Net Profit Margin | 14.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Icrx Life Sciences Private Limited, buy the company report.
Board of directors of Icrx Life Sciences Private Limited
Icrx Life Sciences has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hoyt Randall Smith | Director | 30 Apr 2019 | 7 Years 6 Months | Current |
| Brijesh Magan Bhai Patel | Director | 30 Apr 2019 | 7 Years 6 Months | Current |
| Shital M Patel | Director | 30 Apr 2019 | 7 Years 6 Months | Current |
| Toshakkumar Maganbhai Patel | Director | 25 Jan 2019 | 7 Years 9 Months | Current |
Auditor
Icrx Life Sciences Private Limited is audited by RAHUL AGARWALLA & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAHUL AGARWALLA & CO | FY 2021 | 023451S |
Shareholding
The shareholding of Icrx Life Sciences Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Icrx Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Icrx Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Icrx Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Icrx Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Icrx Life Sciences Private Limited has 6 board changes on record since 2019: 4 appointments and 2 cessations. The latest: Hoyt Randall Smith ceased to be Director on 19 Sep 2024.
Frequently asked questions
Icrx Life Sciences is an active private limited company based in Anand, Gujarat, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 25 January 2019 (7+ years old) and is registered under CIN U74999GJ2019PTC106264.
Icrx Life Sciences has 4 current directors:
- Hoyt Randall Smith - Director
- Brijesh Magan Bhai Patel - Director
- Shital M Patel - Director
- Toshakkumar Maganbhai Patel - Director
The latest financial statements of Icrx Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Icrx Life Sciences is U74999GJ2019PTC106264. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Icrx Life Sciences was incorporated on 25 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Hoyt Randall Smith ceased to be Director on 19 Sep 2024. Hiral Patel ceased to be Director on 16 May 2022. Brijesh Magan Bhai Patel was appointed as Director on 30 Apr 2019. Icrx Life Sciences has 6 board changes on record in total.
The registered office of Icrx Life Sciences is at HNo.5180 Minal Tubewell Office Complex Samarkha Road Village: Samarkha, Anand, Gujarat, India – 388360.
Icrx Life Sciences operates in the business outsourcing industry, in the business and IT consulting segment.
The compliance status of Icrx Life Sciences is compliant as of 21 August 2026. The company is actively filing with the Registrar of Companies.
Icrx Life Sciences can be reached at its registered office: HNo.5180 Minal Tubewell Office Complex Samarkha Road Village: Samarkha, Anand, Gujarat, India – 388360.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
